Cancer News
Drinking coffee daily may lower colon cancer recurrence
Coffee’s caffeine may help colon cancer patients keep the cancer away for longer, according to a new, large study.
Medication adherence in breast cancer: why do patients skip drugs?
The side effects of hormone therapy as well as a poor doctor-patient communication may make breast cancer patients to intentionally or unintentionally miss a dose.
Chemotherapy: ineffective for older breast cancer patients
Chemotherapy proved to be inefficient for breast cancer patients over the age of 70, a new study reveals.
Imbruvica gives hope to rare blood cancer patients
Heavily treated patients with relapsed or refractory mantle cell lymphoma (MCL) showed positive and durable results when treated with Imbruvica, a new report reveals.
Combination therapy improves survival in metastatic prostate cancer
Newly diagnosed patients with metastatic, hormone-sensitive prostate cancer survived longer when treated with a combination of two drugs, a new study reveals.
Improved survival outcomes in ovarian cancer patients
Intraperitoneal chemotherapy proved to be beneficial for women with advanced ovarian cancer, a new study showed.
One step closer to a new multiple myeloma drug in EU
European regulators have granted an accelerated assessment to Takeda’s ixazomib, a new drug for relapsed and/or refractory multiple myeloma.
Two targeted therapies get European recommendation for melanoma
The combination of dabrafenib and trametinib got recommended by European regulators to treat adult melanoma patients with a BRAF V600 mutation.
Understanding the link between cancer and metabolism
Given the absence of scientific evidence relating cancer and food, experts have created four articles describing cancer and obesity, antioxidants and biomarkers.
New approved treatment for advanced skin cancer
Novartis’s oral pill, Odomzo, received approval by the U.S. FDA to treat patients with basal cell carcinoma, the most common form of advanced skin cancer.
Potential harm of chemotherapy in patients with end-stage cancer
A study reveals that for patients with end-stage cancer, still able to perform many life functions, chemotherapy worsened their quality of life.
Breast cancer: Better patient outcomes with current treatments
Two currently available treatments, aromatase inhibitors and bisphosphonates benefited substantially breast cancer patients.
Radiation therapy: a treatment option for some breast cancer patients
A 14-year study reports that additional radiation, although it did not increase overall survival, benefited breast cancer patients as it reduced cancer recurrence.
Good news for patients with metastatic renal cell carcinoma
The results of two phase 3 clinical trials on metastatic renal cell carcinoma showed that patients benefited from two immunotherapeutic agents, nivolumab and cabozantinib.
Gefitinib gets US approval for non-small cell lung cancer
Gefitinib has been approved in the US for the treatment of metastatic non-small cell lung cancer patients with specific tumor characteristics.
Updates on radiation therapy for prostate cancer patients
Increased radiation dose did not benefit low-risk prostate cancer patients, while it raised survival rates in medium and high-risk prostate cancer patients.
Drug combination shows promise in metastatic breast cancer
Combining lapatinib and trastuzumab led to positive outcomes in metastatic breast cancer patients as it proved to be active and well-tolerated.
Chemotherapy linked to weight gain in breast cancer survivors
Chemotherapy may lead to weight gain in breast cancer survivors with a family history of the disease, a new prospective study suggests.
New lung cancer drug gets US approval as first-line treatment
AstraZeneca’s lung cancer drug, Iressa has been given the green light from US regulators, as a first-line treatment for lung cancer.
Fewer side effects for prostate cancer with alternative approach
Watchful waiting or active surveillance may provide an alternative to prostate cancers patients keeping them away from the side effects of aggressive treatments.
Less intensive chemotherapy recommended for children’s cancer
A 10-year trial reveals that children with Wilms’ tumor can avoid doxorubicin, an intensive chemotherapy for this rare type of cancer, without risking their survival.
Chemotherapy plus cetuximab benefited colorectal cancer patients
Patients with metastatic colorectal cancer who are mutation-free in specific genes benefited more from chemotherapy plus cetuximab than with chemotherapy alone.
New advances in the treatment of pre-treated metastatic colorectal cancer
Two treatments of metastatic colorectal cancer, regorafenib and TAS-102 proved to be beneficial for pre-treated patients, the results of new studies confirm.
Longer life for patients with low-grade brain tumors
Patients with low-grade brain tumors live longer now than in the past due to more effective chemotherapies, a new study shows.
Robotic surgery: a beneficial option for bladder cancer patients
Bladder cancer patients treated with robot-assisted surgery showed similar beneficial results to those who underwent a traditional open operation, a new study suggests.
Nivolumab gets EU approval as a treatment of advanced melanoma
The European Commission has approved nivolumab for the treatment of advanced melanoma patients. The approval is based on positive data from two phase 3 studies.
Cryopreservation boosts fertility hopes to breast cancer patients
Breast cancer patients were able to conceive after treatment using embryo cryopreservation after ovarian stimulation, according to a new study.
Vitamin D and weight loss to reduce inflammation linked to cancer
Combining weight loss with vitamin D had better results in reducing chronic inflammation. Chronic inflammation is linked to the development of some cancers.
Immunotherapy and epigenetics to treat leukemia and other cancers
Experimental treatment offered critical time for patients of a rare, deadly leukemia, offering also a potential treatment option for other cancers, a small study shows.
Better patient outcomes with new breast cancer treatment
Breast cancer patients treated with a one-week partial breast irradiation saw no increase in cancer recurrence or difference in cosmetic outcomes compared to women who received standard treatment.